Yahoo
HKSE - Delayed Quote HKD

Gushengtang Holdings Limited (2273.HK)

28.080 -0.120 (-0.43%)
At close: 4:08:06 PM GMT+8
Chart Range Bar
Loading chart for 2273.HK
  • Previous Close 28.200
  • Open 28.040
  • Bid 28.080 x --
  • Ask 28.180 x --
  • Day's Range 28.020 - 28.720
  • 52 Week Range 24.320 - 32.280
  • Volume 719,100
  • Avg. Volume 650,029
  • Market Cap (intraday) 5.937B
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) 16.62
  • EPS (TTM) 1.690
  • Earnings Date --
  • Forward Dividend & Yield 2.30 (8.16%)
  • Ex-Dividend Date Sep 30, 2026
  • 1y Target Est 40.21

Gushengtang Holdings Limited, an investment holding company, provides healthcare services in the People's Republic of China and Singapore. It offers consultation, traditional massage, moxibustion, acupuncture, and other therapies. The company is also involved in the wholesale of pharmaceutical products; and provision of investment management and supply chain management services. It provides its services through offline medical institutions and online healthcare platforms. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. Gushengtang Holdings Limited was founded in 2010 and is headquartered in Guangzhou, the People's Republic of China.

www.gstzy.cn

4,214

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2273.HK
7.60%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

2273.HK
5.41%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

2273.HK
35.39%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

2273.HK
15.93%
HANG SENG INDEX (^HSI)
8.21%

Analyst Insights

View More

Analyst Price Targets

25.30
40.21 Average
28.080 Current
60.15 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.38%

  • Return on Assets (ttm)

    6.55%

  • Return on Equity (ttm)

    19.63%

  • Revenue (ttm)

    3.41B

  • Net Income Avi to Common (ttm)

    421.83M

  • Diluted EPS (ttm)

    1.690

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.18B

  • Total Debt/Equity (mrq)

    80.97%

  • Levered Free Cash Flow (ttm)

    221.88M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: